Frontlight ResearchEarly access
Chronic kidney disease trials in Colombia
5 of 6 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Barranquilla, Bogotá, Cali, Manizales, Medellín, Montería, Pasto
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Not yet taking people in ColombiaA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Armenia, Barranquilla, Bogotá, Bogotá D.C., Cali, Floridablanca, Manizales, Pasto, Pereira, Punta de Cartagena
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 3Active, not recruitingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Barranquilla, Medellín
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - No phaseNot yet taking people in ColombiaMulti-Site STARgraft (10401) Trial
- Where
- Cali, Medellín
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Healionics Corporation
See details and how to joinNCT07557862 - No phaseNot yet taking people in ColombiaEfficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
- Where
- Bogotá
- Age
- 18 years and over
- People
- 30
- Run by
- Hospital Universitario San Ignacio
See details and how to joinNCT07668219